中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
15期
137-138
,共2页
支气管哮喘%沙美特罗替卡松粉吸入剂%临床疗效
支氣管哮喘%沙美特囉替卡鬆粉吸入劑%臨床療效
지기관효천%사미특라체잡송분흡입제%림상료효
Asthma%Shah Mette Lo fluticasone%Clinical curative effect
目的：探究沙美特罗替卡松粉吸入剂治疗支气管哮喘的临床疗效。方法选取支气管哮喘患者87例，随机法分为对照组43例和观察组44例，对照组采用普米克气雾剂治疗，观察组采用沙美特罗替卡松粉吸入剂治疗。结果观察组患者治疗总有效率较对照组高（P <0.05）），数据比较差异具有统计学意义；两组患者不良反应发生率比较无明显差异（P >0.05），无统计学意义。结论支气管哮喘采用沙美特罗替卡松粉吸入剂治疗，临床疗效显著。
目的：探究沙美特囉替卡鬆粉吸入劑治療支氣管哮喘的臨床療效。方法選取支氣管哮喘患者87例，隨機法分為對照組43例和觀察組44例，對照組採用普米剋氣霧劑治療，觀察組採用沙美特囉替卡鬆粉吸入劑治療。結果觀察組患者治療總有效率較對照組高（P <0.05）），數據比較差異具有統計學意義；兩組患者不良反應髮生率比較無明顯差異（P >0.05），無統計學意義。結論支氣管哮喘採用沙美特囉替卡鬆粉吸入劑治療，臨床療效顯著。
목적：탐구사미특라체잡송분흡입제치료지기관효천적림상료효。방법선취지기관효천환자87례，수궤법분위대조조43례화관찰조44례，대조조채용보미극기무제치료，관찰조채용사미특라체잡송분흡입제치료。결과관찰조환자치료총유효솔교대조조고（P <0.05）），수거비교차이구유통계학의의；량조환자불량반응발생솔비교무명현차이（P >0.05），무통계학의의。결론지기관효천채용사미특라체잡송분흡입제치료，림상료효현저。
Objective To explore clinical efficacy of Shah Mette Lo fluticasone propionate in the treatment of bronchial asthma.Methods A total of 87 cases of patients with bronchial asthma, were randomly divided into control group of 43 cases and 44 cases in the observation group,the control group was treated with Pulmicort aerosol agent,observation group were treated with fluticasone propionate in the treatment of Shah Mette Lo.Results Patients in the observation group the total effective rate is higher than the control group(P < 0.05),statisticaly significant differences between two groups of data;the incidence rate of adverse reaction had no significant difference(P > 0.05),no statistical significance.Conclusion Bronchial asthma by Shah Mette Lo fluticasone therapy,clinical curative effect.
